ATHE Alterity publishes latest quarterly earnings report outlining new advancement plans for its lead neurological drug candidate AMPX Amprius stock falls 492 after Q4 2025 EPS misses estimates by a wide margin ProShares Ultra VIX ShortTerm Futures ETF UVXY Included in Broad ProShares ETF Forward and Reverse Share Split Announcement